SCHEMBL7858714

SCHEMBL7858714

CCOC(=O)C(O)(Cn1ccnc1)P(=O)(OCC)OCC

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.47
GGPS1 O95749 3/20 0.46
BTN3A1 O00481 1/20 0.46
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
LMNA P02545 1/20 0.46
MMP2 P08253 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
MMP14 P50281 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
TBXAS1 P24557 6/20 0.39
CYP26A1 O43174 1/20 0.37
ALDH1A1 P00352 2/20 0.36
ABL1 P00519 1/20 0.34
RIN1 Q13671 1/20 0.34
EGLN3 Q9H6Z9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7852810 0.88 FDPS (0.49) FDPSGGPS1BTN3A1CA12CA2
SCHEMBL8843613 0.77 FDPS (0.51) FDPSGGPS1BTN3A1CA12CA2
SCHEMBL19799422 0.75 FDPS (0.46) FDPSGGPS1BTN3A1CA12CA2
SCHEMBL10468127 0.72 MAPT (0.37) LMNAALDH1A1
SCHEMBL19792826 0.72 FDPS (0.43) FDPSGGPS1BTN3A1CA12CA2
SCHEMBL7853015 0.69 FDPS (0.66) FDPSGGPS1BTN3A1CA12CA2
SCHEMBL9716426 0.69 TBXAS1 (0.52) FDPSLMNATBXAS1EGLN3
Diethyl Hydrogen Phosphate SCHEMBL4951600 0.67 FDPS (0.47) FDPSGGPS1BTN3A1CA12CA2
SCHEMBL563845 0.67 ALDH1A1 (0.56) TBXAS1ALDH1A1ABL1RIN1EGLN3
SCHEMBL4903214 0.66 MAPK1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0788362-B1 PHOSPONOCARBOXYLATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMA (US) 2001-07-25 EP disclosed
US-5760021-A TREATING OR PREVENTING METABOLIC BONE DISORDERS THE PROCTER & GAMBLE COMPANY (US) 1998-06-02 US disclosed
EP-0788362-A1 PHOSPONOCARBOXYLATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) 1997-08-13 EP disclosed
WO-1993024131-A1 PHOSPONOCARBOXYLATE COMPOUNDS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM PROCTER & GAMBLE PHARMACEUTICALS, INC. (US) 1993-12-09 WO disclosed